Risk Factors for Early Recurrence of Resectable Pancreatic Cancer
T3 tumors and R1 resection were independent predictive factors for ER and poor prognosis following resection. Multidisciplinary therapy should be considered for patients with RPC with T3 tumors or tumors ≥25 mm in size.
Authors
- Tomoki Nakafusa
- Masafumi Nakamura (ORCID: https://orcid.org/0000-0002-6196-8643)
- Takashi Taniguchi (ORCID: https://orcid.org/0000-0003-0017-7669)
- Noboru Ideno (ORCID: https://orcid.org/0000-0003-4745-8417)
- Ryuichiro Kimura (ORCID: https://orcid.org/0000-0001-5278-7827)
- Yoshinao Oda (ORCID: https://orcid.org/0000-0001-9636-1182)
- Takahiro Tomosugi
- Yoshihiro Miyasaka (ORCID: https://orcid.org/0000-0003-4344-4448)
- Takao Ohtsuka (ORCID: https://orcid.org/0000-0002-2946-1092)
- Kohei Nakata (ORCID: https://orcid.org/0000-0002-5717-8569)
- Kosuke Noma (ORCID: https://orcid.org/0009-0009-9415-9744)
- Takeo Yamamoto
- Yasuhisa Mori
Institutions
- Kagoshima University (JP)
- Kyushu University (JP)
- University of Occupational and Environmental Health Japan (JP)
- Fukuoka University (JP)
- Miyazaki Prefectural Hospital (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.21873/anticanres.17792
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00